Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars

NCT02286648 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-11-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical and radiographic success rate of Miniature pulpotomy with Mineral Trioxide Aggregate (MTA) in primary molars.

Conditions

  • Pulpitis
  • Dental Pulp Disease
  • Tooth Diseases

Interventions

DRUG

Formocresol

pulpotomy with formocresol

DRUG

Mineral Trioxide Aggregate

pulpotomy with MTA

Sponsors & Collaborators

  • Mashhad University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-07-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02286648 on ClinicalTrials.gov